ReportWire

Tag: coronary artery disease

  • Matthew Perry died from acute effects of ketamine, officials rule

    Matthew Perry died from acute effects of ketamine, officials rule

    [ad_1]

    Matthew Perry died from acute effects of ketamine, a drug sometimes used to treat depression, officials said.

    The ketamine caused cardiovascular overstimulation and respiratory depression, the Los Angeles County medical examiner said. Other contributing factors in the actor’s death included drowning, coronary artery disease and the effects of buprenorphine, a medication used to treat opioid use disorder.

    Perry’s Oct. 28 death was an accident, according to an autopsy.

    The actor was best known for playing the sarcastic and witty Chandler Bing on NBC’s “Friends” for 10 seasons, from 1994 to 2004. In his 2022 memoir, Perry said he began abusing substances at the age of 14 and landed the role on “Friends” a decade later. Fame increased his dependency on alcohol and drugs. At one point, he said in his book, he took nearly five dozen pills a day.

    Following his death at his home in Pacific Palisades, trace amounts of ketamine were found in Perry’s stomach, the medical examiner noted. The level found in his blood was about the same quantity as would be used during general anesthesia.

    According to the report, Perry had been playing pickleball at about 11 that morning, and his live-in assistant last saw him at 1:37 p.m.

    Upon returning to Perry’s home on Blue Sail Drive, the assistant found him floating face-down in his swimming pool. The assistant jumped in, pulled Perry’s head out of the water and called 911.

    Paramedics arrived and moved Perry onto the grass, where he was pronounced dead.

    The report noted that Perry had no other drugs in his system and had been 19 months sober at the time of his death. There was no evidence of illicit drugs or paraphernalia at Perry’s home.

    Perry was undergoing ketamine infusion therapy every other day for a period of time but had reduced that intake more recently, and his last known infusion was a week and a half before his death.

    The medical examiner noted the ketamine could not have been from that session as it typically disappears from the system in detectable amounts within three to four hours.

    The medical examiner also noted that Perry, 54, had diabetes and suffered from chronic obstructive pulmonary disease, which refers to a group of diseases that cause airflow blockage and breathing-related problems. He also smoked two packs of cigarettes a day.

    A coroner’s investigator interviewed a person close to Perry who described him as in “good spirits” and said he had quit smoking two weeks prior to his death and was weaning himself off ketamine.

    A legal medication commonly used medically as an anesthetic, ketamine has been increasingly offered “off label” at private clinics in an effort to treat depression and other mental health disorders, said Dr. David Goodman-Meza, an addiction medicine and infectious disease specialist at UCLA.

    Some people also snort or inject it recreationally to experience euphoric or “dissociative” effects that cause someone to feel separated from their own body, Goodman-Meza said. At very high doses, it can make people feel immobilized and spur hallucinations, an experience called a “K-hole.”

    The drug can complicate breathing and increase demands on the heart. If someone already has coronary artery disease and is taking high doses of ketamine, “that could then speed up your heart, create more demand, but then your arteries don’t have the ability to supply that demand,” the physician explained.

    Tucker Avra, a UCLA medical student who works with people recovering from ketamine addiction, said that people using ketamine can also be at risk of passing out or falling down. “If you’re in water,” he said, there’s “a risk of drowning by basically putting yourself under anesthesia by using it.”

    Avra said those using ketamine should test their drugs for the synthetic opioid fentanyl, have Narcan on hand to reverse an opioid overdose in case the drug is contaminated with opioids, and avoid using the drug alone. He said he hoped the tragedy of Perry’s death might encourage doctors to learn more about the side effects of recreational use.

    In 2006, the National Institute of Mental Health concluded that an intravenous dose of ketamine had rapid antidepressant effects. About 300 clinical trials have been held, and they have broadly found that ketamine is extremely fast-acting compared with traditional antidepressants and can relieve depression for a period that can last days or weeks.

    A prescription version of ketamine called Spravato, given through a nasal spray, was approved in 2019 by the FDA for treatment-resistant depression. The number of ketamine clinics in the U.S. has risen from a few dozen to several hundred in the last few years.

    “Ketamine overdose by itself is exceedingly rare,” said Dr. Siddarth Puri, associate medical director of prevention for the Substance Abuse Prevention and Control division at L.A. County’s public health department.

    In general, much of the overdose concern around ketamine surrounds mixing it with other substances that can also affect breathing or heart rate, such as alcohol or opioids, he said.

    People are also at higher risk of bad outcomes if they have underlying conditions such as high blood pressure or breathing problems, Puri said. In medical settings, Puri said, “your doctor is making sure your heart can manage and respond to ketamine appropriately, your breathing is OK … you’re not having any kind of allergic reaction,” and other medications will not compound its effects.

    Perry described taking ketamine infusions in his memoir, “Friends, Lovers, and the Big Terrible Thing.”

    “It’s used for two reasons: to ease pain and help with depression. Has my name written all over it — they might as well have called it ‘Matty,’” he wrote. “Ketamine felt like a giant exhale. They’d bring me into a room, sit me down, put headphones on me so I could listen to music, blindfold me, and put an IV in.”

    He wrote that he would “disassociate” while listening to music and “often thought that I was dying during that hour.”

    [ad_2]

    Richard Winton, Emily Alpert Reyes

    Source link

  • Daily Marijuana Use Now Linked to Heart Risks

    Daily Marijuana Use Now Linked to Heart Risks

    [ad_1]

    By Steven Reinberg 

    HealthDay Reporter

    MONDAY, Feb. 27, 2023 (HealthDay News) — New research suggests that smoking weed is far from benign: Toking every day might raise your odds of heart disease.

    The increased risk is not insignificant. Daily marijuana users are about one-third more likely to develop coronary artery disease, compared with people who have never used the drug, researchers say.

    Marijuana is becoming more widely available and its link with heart disease is concerning, lead researcher Dr. Ishan Paranjpe, a resident at Stanford University in California, said during a media briefing on the findings.

    “Cannabis potency has actually increased over the past couple of decades,” Paranjpe said. “From a public policy standpoint, it’s now legalized in 39 states and there’s a very large legal cannabis market as well. From a medical standpoint, there’s been a few smaller observational studies and prospective cohort studies in which they’ve looked at the cardiovascular effects of cannabis use.”

    For the study, Paranjpe and his colleagues used the All of Us Research Program of the U.S. National Institutes of Health, to collect data on the health and habits of 175,000 people and their marijuana use.

    To increase the chances that their findings might determine if marijuana caused an increase in the risk of heart disease, they used a genetics-based approach called Mendelian randomization with data from an independent genetics group.

    After taking into account age, sex and major risk factors for heart disease, the researchers found that cannabis users were 34% more likely to have heart disease than those who had never tried marijuana.

    The investigators found that cannabis use was associated with higher levels of a type of blood fat called triglycerides and LDL (“bad”) cholesterols, as well as higher body mass index (a measurement based on height and weight), Paranjpe said.

    Monthly cannabis use, however, was not linked with a significant increase in the risk of heart disease, they noted.

    While the study could definitively prove cause and effect, the genetic analysis found that the relationship was independent of the effects of tobacco and alcohol use.

    Other studies have suggested that THC (tetrahydrocannabinol), the ingredient in marijuana that produces the psychoactive effects, acts on receptors found in the central nervous system, and the heart and blood vessels.

    THC in blood vessels may produce inflammation and the buildup of plaque, which can lead to heart disease, the researchers suggested.

    “I think this has both public policy implications as well as implications for the medical community at large,” Paranjpe said. “There might also be potential pharmacologic interventions based on this cannabinoid pathway that I think would be amenable to future research.”

    Paranjpe said the effects of marijuana might be even worse for people who already have heart disease.

    “There is some observational data in the past that shows pretty robustly that it leads to an increased risk of heart attacks, but that’s mostly in younger people. What I would say is that physicians can counsel patients with heart disease that it [marijuana] probably doesn’t have a positive effect and might have a negative effect,” he said. “I think the exact effect on the risk of stroke and heart attack is still unknown.”

    The findings are to be presented Sunday at the American College of Cardiology annual meeting, in New Orleans. Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.

    The datasets used in this study did not differentiate between various forms of cannabis use — for example, whether the drug was smoked or consumed in edibles or other forms, the study authors noted.
     

    “There’s still a lot that’s unknown about the relationship between cannabis and heart disease,” said Dr. Jeffrey Kuvin, senior vice president of cardiology at North Shore University Hospital in Manhasset, N.Y.

    Some theories have been proposed on why chronic use of marijuana might lead to heart disease, he said. It could be inflammation or increasing blood pressure or heart rate, or clumping of platelets that can cause clotting or other factors in the blood, or spasming of the arteries, Kuvin said.

    “It remains a little bit unclear, but I think this large-scale study confirms that the chronic use of marijuana could be a risk factor for coronary heart disease,” he said.

    Patients should limit the use of cannabis, Kuvin advised. For anyone with a heart condition, he recommends avoiding cannabis altogether. “I would stay away from it,” he said.

    Kuvin is especially concerned for young people who believe that cannabis is harmless. But the effects of marijuana on the heart may not be seen for years, he said.

    “There’s a lot of potential risk for heart conditions as well as lung issues, and other bodily harm if it’s used on a chronic basis. And I worry that with changes in legislation in terms of its legality, we will only continue the course,” Kuvin said. “If we’re not proactive in our approach we’re going to end up in a similar situation that we have found ourselves in with tobacco, trying to figure out how to increase our awareness and our education about the harm that cannabis can do, just like we do with cigarettes.”

    More information

    For more on marijuana and heart disease, head to the U.S. Centers for Disease Control and Prevention.

     

    SOURCES: Ishan Paranjpe, MD, resident, Stanford University, Stanford, Calif.; Jeffrey Kuvin, MD, senior vice president, cardiology, North Shore University Hospital, Manhasset, N.Y.; presentation, American College of Cardiology annual meeting, New Orleans, March, 5, 2023

    [ad_2]

    Source link

  • Daily users of Marijuana are at high coronary artery disease risk – Medical Marijuana Program Connection

    Daily users of Marijuana are at high coronary artery disease risk – Medical Marijuana Program Connection

    [ad_1]

    New York: Daily users of Marijuana are around one-third more likely to develop coronary artery disease (CAD) than those who never used it, a new study found.

    CAD is the most common form of heart disease and occurs when the arteries that supply blood to the heart become narrowed due to a buildup of cholesterol. CAD commonly causes chest pain, shortness of breath and fatigue and can lead to a heart attack.

    “We found that cannabis use is linked to CAD, and there seems to be a dose-response relationship in that more frequent cannabis use is associated with a higher risk of CAD,” said lead author Ishan Paranjpe, from Stanford University.

    “In terms of the public health message, it shows that there are probably certain harms of cannabis use that weren’t recognised before, and people should take that into account,” he added.

    The team included 175,000 people in the study. The results indicated that daily cannabis users were 34 per cent more likely to have CAD than those who have never used Marijuana.

    In contrast, monthly cannabis use was not associated with a significant increase in the risk of CAD.

    Based on these findings, researchers said it is important for people to be aware that cannabis use is not without risk and make sure to inform their doctor if they use cannabis so that clinicians can take appropriate steps to monitor their heart health.

    By helping to better understand the molecular pathways involved in marijuana use and heart disease, the findings could open new opportunities…

    Original Author Link click here to read complete story..

    [ad_2]

    MMP News Author

    Source link